NCR Atleos (NATL) Financials

NCR Atleos logo
$47.60 -0.08 (-0.17%)
As of 03:59 PM Eastern
Annual Income Statements for NCR Atleos

Annual Income Statements for NCR Atleos

This table shows NCR Atleos' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
99 -150 80 162
Consolidated Net Income / (Loss)
98 -148 81 162
Net Income / (Loss) Continuing Operations
-7.00 -242 81 162
Total Pre-Tax Income
146 89 125 189
Total Operating Income
258 263 437 478
Total Gross Profit
803 834 1,020 1,061
Total Revenue
4,122 4,186 4,305 4,354
Operating Revenue
4,122 4,186 4,305 4,354
Total Cost of Revenue
3,319 3,352 3,285 3,293
Operating Cost of Revenue
3,319 3,352 3,285 3,293
Total Operating Expenses
650 665 583 583
Selling, General & Admin Expense
586 585 521 513
Research & Development Expense
64 80 62 70
Total Other Income / (Expense), net
-112 -174 -312 -289
Interest Expense
31 90 333 270
Other Income / (Expense), net
-81 -84 21 -19
Income Tax Expense
48 237 44 27
Net Income / (Loss) Attributable to Noncontrolling Interest
-1.00 2.00 1.00 0.00
Basic Earnings per Share
$1.40 ($2.12) $1.11 $2.20
Weighted Average Basic Shares Outstanding
70.60M 70.60M 72.20M 73.50M
Diluted Earnings per Share
$1.40 ($2.12) $1.08 $2.14
Weighted Average Diluted Shares Outstanding
70.60M 70.60M 74.20M 75.60M
Weighted Average Basic & Diluted Shares Outstanding
- - 73.04M 73.56M

Quarterly Income Statements for NCR Atleos

This table shows NCR Atleos' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-8.00 30 21 34 14 39 26 74 22 65 97
Consolidated Net Income / (Loss)
-8.00 29 20 37 13 38 26 76 22 65 97
Net Income / (Loss) Continuing Operations
-8.00 29 20 37 13 38 26 76 22 65 97
Total Pre-Tax Income
-4.00 33 30 59 22 57 33 67 33 90 129
Total Operating Income
72 108 114 138 93 119 110 152 84 156 183
Total Gross Profit
221 251 256 286 232 252 271 302 234 309 283
Total Revenue
1,050 1,080 1,073 1,097 979 1,102 1,121 1,149 1,043 1,103 1,099
Operating Revenue
1,050 1,080 1,073 1,097 979 1,102 1,121 1,149 1,043 1,103 1,099
Total Cost of Revenue
829 829 817 811 747 850 850 847 809 794 816
Operating Cost of Revenue
829 829 817 811 747 850 850 847 809 794 816
Total Operating Expenses
149 143 142 148 139 133 161 150 150 153 100
Selling, General & Admin Expense
132 132 127 130 122 116 143 132 130 133 82
Research & Development Expense
17 11 15 18 17 17 18 18 20 20 18
Total Other Income / (Expense), net
-76 -75 -84 -79 -71 -62 -77 -85 -51 -66 -54
Interest Expense
79 79 79 96 67 69 68 66 63 62 61
Other Income / (Expense), net
3.00 4.00 -5.00 17 -4.00 7.00 -9.00 -19 12 -4.00 7.00
Income Tax Expense
4.00 4.00 10 22 9.00 19 7.00 -9.00 11 25 32
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 -1.00 -1.00 3.00 -1.00 -1.00 0.00 2.00 0.00 0.00 0.00
Basic Earnings per Share
($0.11) $0.42 $0.29 $0.47 $0.19 $0.53 $0.35 $1.01 $0.30 $0.88 $1.31
Weighted Average Basic Shares Outstanding
71.60M 72.20M 72.30M 72.20M 73.10M 73.50M 73.70M 73.50M 73.60M 73.80M 73.90M
Diluted Earnings per Share
($0.11) $0.41 $0.28 $0.46 $0.19 $0.52 $0.34 $0.97 $0.29 $0.86 $1.27
Weighted Average Diluted Shares Outstanding
71.60M 73.70M 74.50M 74.20M 75.20M 74.90M 76M 75.60M 75.60M 75.80M 76.10M
Weighted Average Basic & Diluted Shares Outstanding
72.12M 72.32M 72.49M 73.04M 73.45M 73.59M 73.90M 73.56M 73.78M 73.90M 73.94M

Annual Cash Flow Statements for NCR Atleos

This table details how cash moves in and out of NCR Atleos' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
40 70 55 3.00
Net Cash From Operating Activities
274 355 344 356
Net Cash From Continuing Operating Activities
274 355 344 356
Net Income / (Loss) Continuing Operations
98 -148 81 162
Consolidated Net Income / (Loss)
98 -148 81 162
Depreciation Expense
127 254 287 277
Non-Cash Adjustments To Reconcile Net Income
118 -97 -7.00 -47
Changes in Operating Assets and Liabilities, net
-201 346 -17 -36
Net Cash From Investing Activities
-417 -316 -135 -116
Net Cash From Continuing Investing Activities
-417 -316 -135 -116
Purchase of Property, Plant & Equipment
-97 -132 -126 -156
Acquisitions
-78 -1.00 -13 -17
Purchase of Investments
0.00 -10 4.00 1.00
Sale of Property, Plant & Equipment
- 0.00 0.00 45
Divestitures
0.00 0.00 1.00 11
Other Investing Activities, net
-242 -173 -1.00 0.00
Net Cash From Financing Activities
183 31 -134 -253
Net Cash From Continuing Financing Activities
183 31 -134 -253
Repayment of Debt
-604 -541 -1,519 -1,172
Repurchase of Common Equity
- 0.00 0.00 -28
Issuance of Debt
68 3,636 1,404 976
Issuance of Common Equity
0.00 0.00 4.00 11
Other Financing Activities, net
719 -3,064 -23 -40
Effect of Exchange Rate Changes
- - -20 16

Quarterly Cash Flow Statements for NCR Atleos

This table details how cash moves in and out of NCR Atleos' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
21 23 54 -43 41 -32 -63 57 -48 9.00 -114
Net Cash From Operating Activities
148 9.00 107 80 123 -23 25 231 -9.00 30 198
Net Cash From Continuing Operating Activities
148 9.00 107 81 123 -23 25 231 -9.00 30 198
Net Income / (Loss) Continuing Operations
-8.00 30 15 38 13 42 19 85 22 65 97
Consolidated Net Income / (Loss)
-8.00 30 15 38 13 42 19 85 22 65 97
Depreciation Expense
73 71 74 35 69 72 70 66 70 72 72
Non-Cash Adjustments To Reconcile Net Income
-2.00 - 9.00 - 1.00 -24 -14 -10 -11 -22 -20
Changes in Operating Assets and Liabilities, net
85 -92 9.00 -26 40 -113 -50 90 -90 -85 49
Net Cash From Investing Activities
-31 -40 -39 -25 -37 - -51 -28 -25 -27 -50
Net Cash From Continuing Investing Activities
-31 -40 -39 -25 -37 - -51 -28 -25 -27 -50
Purchase of Property, Plant & Equipment
-30 -32 -33 -31 -41 -35 -43 -37 -37 -37 -63
Sale of Property, Plant & Equipment
- - - - - - 12 9.00 - - 13
Net Cash From Financing Activities
-87 57 -19 -85 -49 -17 -36 -151 -11 5.00 -261
Net Cash From Continuing Financing Activities
-87 57 -19 -85 -49 -17 -36 -151 -11 5.00 -261
Repayment of Debt
-155 -395 -401 -568 -175 -312 -356 -329 -239 -170 -344
Issuance of Debt
74 459 386 485 150 290 321 215 260 180 90
Other Financing Activities, net
-6.00 -8.00 -6.00 -3.00 -24 -2.00 -1.00 -13 -16 -5.00 -7.00
Effect of Exchange Rate Changes
-9.00 -3.00 5.00 - 4.00 8.00 -1.00 5.00 -3.00 1.00 -1.00

Annual Balance Sheets for NCR Atleos

This table presents NCR Atleos' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets
5,702 5,535 5,668
Total Current Assets
1,861 1,749 1,824
Cash & Equivalents
339 419 456
Restricted Cash
238 210 175
Accounts Receivable
707 581 550
Inventories, net
333 307 342
Other Current Assets
244 232 301
Plant, Property, & Equipment, net
468 474 511
Total Noncurrent Assets
3,373 3,312 3,333
Goodwill
1,952 1,950 1,958
Intangible Assets
635 550 498
Noncurrent Deferred & Refundable Income Taxes
254 285 288
Employee Benefit Assets
219 227 259
Other Noncurrent Operating Assets
313 300 330
Total Liabilities & Shareholders' Equity
5,702 5,535 5,668
Total Liabilities
5,480 5,312 5,266
Total Current Liabilities
1,773 1,722 1,899
Short-Term Debt
76 81 86
Accounts Payable
505 564 617
Current Deferred Revenue
332 328 383
Current Employee Benefit Liabilities
149 145 139
Other Current Liabilities
711 604 674
Total Noncurrent Liabilities
3,707 3,590 3,367
Long-Term Debt
2,938 2,859 2,672
Noncurrent Deferred Revenue
36 37 24
Noncurrent Deferred & Payable Income Tax Liabilities
34 40 41
Noncurrent Employee Benefit Liabilities
449 424 356
Other Noncurrent Operating Liabilities
250 230 274
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
222 223 402
Total Preferred & Common Equity
219 219 403
Preferred Stock
0.00 0.00 0.00
Total Common Equity
219 219 403
Common Stock
13 48 66
Retained Earnings
117 188 299
Accumulated Other Comprehensive Income / (Loss)
89 -17 38
Noncontrolling Interest
3.00 4.00 -1.00

Quarterly Balance Sheets for NCR Atleos

This table presents NCR Atleos' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
5,776 5,765 5,748 5,739 5,814 5,650 5,641 5,664 5,506
Total Current Assets
1,983 1,979 1,931 1,937 1,976 1,817 1,815 1,848 1,651
Cash & Equivalents
343 374 395 352 357 412 433 429 311
Restricted Cash
256 249 279 316 279 162 151 164 166
Accounts Receivable
742 707 623 658 669 569 575 601 519
Inventories, net
330 329 351 356 400 383 366 351 362
Other Current Assets
312 320 283 255 271 291 290 303 293
Plant, Property, & Equipment, net
461 457 457 479 480 484 509 524 539
Total Noncurrent Assets
3,332 3,329 3,360 3,323 3,358 3,349 3,317 3,292 3,316
Goodwill
1,951 1,951 1,954 1,951 1,953 1,959 1,958 1,957 1,957
Intangible Assets
606 596 583 553 534 519 474 451 430
Noncurrent Deferred & Refundable Income Taxes
253 265 285 297 305 290 283 279 275
Employee Benefit Assets
215 221 238 237 261 262 263 263 266
Other Noncurrent Operating Assets
307 296 300 285 305 319 339 342 388
Total Liabilities & Shareholders' Equity
5,776 5,765 5,748 5,739 5,814 5,650 5,641 5,664 5,506
Total Liabilities
5,489 5,514 5,486 5,461 5,462 5,319 5,245 5,200 4,943
Total Current Liabilities
1,883 1,853 1,799 1,888 1,887 1,784 1,851 1,802 1,825
Short-Term Debt
80 84 88 81 81 80 80 84 89
Accounts Payable
530 571 545 542 593 530 597 597 643
Current Deferred Revenue
332 318 304 403 395 358 435 408 383
Current Employee Benefit Liabilities
132 145 152 120 119 137 106 104 123
Other Current Liabilities
809 735 710 742 699 679 633 609 587
Total Noncurrent Liabilities
3,606 3,661 3,687 3,573 3,575 3,535 3,394 3,398 3,118
Long-Term Debt
2,857 2,921 2,906 2,833 2,816 2,789 2,703 2,711 2,455
Noncurrent Deferred Revenue
36 37 38 37 34 35 24 26 27
Noncurrent Deferred & Payable Income Tax Liabilities
29 29 34 47 50 53 41 37 37
Noncurrent Employee Benefit Liabilities
447 445 445 425 425 410 358 344 318
Other Noncurrent Operating Liabilities
237 229 264 231 250 248 268 280 281
Commitments & Contingencies
- - - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
287 251 262 278 352 331 396 464 563
Total Preferred & Common Equity
283 250 264 275 350 330 396 464 564
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
283 250 264 275 350 330 396 464 564
Common Stock
15 24 32 49 56 65 67 76 84
Retained Earnings
165 167 191 249 276 268 306 371 468
Accumulated Other Comprehensive Income / (Loss)
103 59 41 -23 18 -3.00 23 17 12
Noncontrolling Interest
4.00 1.00 -2.00 3.00 2.00 1.00 0.00 0.00 -1.00

Annual Metrics And Ratios for NCR Atleos

This table displays calculated financial ratios and metrics derived from NCR Atleos' official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - 73,904,136.00
DEI Adjusted Shares Outstanding
- - - 73,904,136.00
DEI Earnings Per Adjusted Shares Outstanding
- - - 2.19
Growth Metrics
- - - -
Revenue Growth
0.00% 1.55% 2.84% 1.14%
EBITDA Growth
0.00% -0.69% 72.06% -1.21%
EBIT Growth
0.00% 1.13% 155.87% 0.22%
NOPAT Growth
0.00% -352.54% 164.75% 44.69%
Net Income Growth
0.00% -251.02% 154.73% 100.00%
EPS Growth
0.00% -251.43% 150.94% 98.15%
Operating Cash Flow Growth
0.00% 29.56% -3.10% 3.49%
Free Cash Flow Firm Growth
0.00% 0.00% 113.18% 1.60%
Invested Capital Growth
0.00% 0.00% -4.70% -0.20%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 1.09%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 18.71%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -5.94%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 30.35%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 28.57%
EPS Q/Q Growth
0.00% 0.00% 0.00% 28.14%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 73.66%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 53.41%
Invested Capital Q/Q Growth
0.00% 0.00% -1.86% -3.69%
Profitability Metrics
- - - -
Gross Margin
19.48% 19.92% 23.69% 24.37%
EBITDA Margin
10.58% 10.34% 17.31% 16.90%
Operating Margin
6.26% 6.28% 10.15% 10.98%
EBIT Margin
4.29% 4.28% 10.64% 10.54%
Profit (Net Income) Margin
2.38% -3.54% 1.88% 3.72%
Tax Burden Percent
67.12% -166.29% 64.80% 85.71%
Interest Burden Percent
82.49% 49.72% 27.29% 41.18%
Effective Tax Rate
32.88% 266.29% 35.20% 14.29%
Return on Invested Capital (ROIC)
0.00% -32.90% 10.91% 16.18%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -9.15% 2.39% 5.02%
Return on Net Nonoperating Assets (RNNOA)
0.00% -100.44% 25.50% 35.66%
Return on Equity (ROE)
0.00% -133.33% 36.40% 51.84%
Cash Return on Invested Capital (CROIC)
0.00% -232.90% 15.72% 16.38%
Operating Return on Assets (OROA)
0.00% 3.14% 8.15% 8.19%
Return on Assets (ROA)
0.00% -2.60% 1.44% 2.89%
Return on Common Equity (ROCE)
0.00% -131.53% 35.83% 51.59%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
173 -437 283 410
NOPAT Margin
4.20% -10.45% 6.58% 9.41%
Net Nonoperating Expense Percent (NNEP)
0.00% -23.75% 8.52% 11.16%
Return On Investment Capital (ROIC_SIMPLE)
- -13.52% 8.95% 12.97%
Cost of Revenue to Revenue
80.52% 80.08% 76.31% 75.63%
SG&A Expenses to Revenue
14.22% 13.98% 12.10% 11.78%
R&D to Revenue
1.55% 1.91% 1.44% 1.61%
Operating Expenses to Revenue
15.77% 15.89% 13.54% 13.39%
Earnings before Interest and Taxes (EBIT)
177 179 458 459
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
436 433 745 736
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 0.00 11.23 6.99
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.57 0.65
Price to Earnings (P/E)
0.00 0.00 30.73 17.39
Dividend Yield
0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 3.25% 5.75%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.88 1.95
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 1.11 1.14
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 6.41 6.72
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 10.42 10.77
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 16.86 12.06
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 13.88 13.88
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 11.70 11.92
Leverage & Solvency
- - - -
Debt to Equity
0.00 13.58 13.18 6.86
Long-Term Debt to Equity
0.00 13.23 12.82 6.65
Financial Leverage
0.00 10.98 10.67 7.10
Leverage Ratio
0.00 25.68 25.25 17.92
Compound Leverage Factor
0.00 12.77 6.89 7.38
Debt to Total Capital
0.00% 93.14% 92.95% 87.28%
Short-Term Debt to Total Capital
0.00% 2.35% 2.56% 2.72%
Long-Term Debt to Total Capital
0.00% 90.79% 90.39% 84.56%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.09% 0.13% -0.03%
Common Equity to Total Capital
0.00% 6.77% 6.92% 12.75%
Debt to EBITDA
0.00 6.96 3.95 3.75
Net Debt to EBITDA
0.00 5.63 3.10 2.89
Long-Term Debt to EBITDA
0.00 6.79 3.84 3.63
Debt to NOPAT
0.00 -6.89 10.38 6.73
Net Debt to NOPAT
0.00 -5.57 8.16 5.19
Long-Term Debt to NOPAT
0.00 -6.72 10.10 6.52
Altman Z-Score
0.00 0.00 1.38 1.41
Noncontrolling Interest Sharing Ratio
0.00% 1.35% 1.57% 0.48%
Liquidity Ratios
- - - -
Current Ratio
0.00 1.05 1.02 0.96
Quick Ratio
0.00 0.59 0.58 0.53
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 -3,096 408 415
Operating Cash Flow to CapEx
282.47% 268.94% 273.02% 320.72%
Free Cash Flow to Firm to Interest Expense
0.00 -34.40 1.23 1.54
Operating Cash Flow to Interest Expense
8.84 3.94 1.03 1.32
Operating Cash Flow Less CapEx to Interest Expense
5.71 2.48 0.65 0.91
Efficiency Ratios
- - - -
Asset Turnover
0.00 0.73 0.77 0.78
Accounts Receivable Turnover
0.00 5.92 6.68 7.70
Inventory Turnover
0.00 10.07 10.27 10.15
Fixed Asset Turnover
0.00 8.94 9.14 8.84
Accounts Payable Turnover
0.00 6.64 6.15 5.58
Days Sales Outstanding (DSO)
0.00 61.65 54.60 47.41
Days Inventory Outstanding (DIO)
0.00 36.26 35.56 35.97
Days Payable Outstanding (DPO)
0.00 54.99 59.39 65.45
Cash Conversion Cycle (CCC)
0.00 42.92 30.77 17.92
Capital & Investment Metrics
- - - -
Invested Capital
0.00 2,659 2,534 2,529
Invested Capital Turnover
0.00 3.15 1.66 1.72
Increase / (Decrease) in Invested Capital
0.00 2,659 -125 -5.00
Enterprise Value (EV)
0.00 0.00 4,774 4,942
Market Capitalization
0.00 0.00 2,459 2,816
Book Value per Share
$0.00 $3.10 $3.02 $5.45
Tangible Book Value per Share
$0.00 ($33.54) ($31.47) ($27.78)
Total Capital
0.00 3,236 3,163 3,160
Total Debt
0.00 3,014 2,940 2,758
Total Long-Term Debt
0.00 2,938 2,859 2,672
Net Debt
0.00 2,437 2,311 2,127
Capital Expenditures (CapEx)
97 132 126 111
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -413 -521 -620
Debt-free Net Working Capital (DFNWC)
0.00 164 108 11
Net Working Capital (NWC)
0.00 88 27 -75
Net Nonoperating Expense (NNE)
75 -289 202 248
Net Nonoperating Obligations (NNO)
0.00 2,437 2,311 2,127
Total Depreciation and Amortization (D&A)
259 254 287 277
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -9.87% -12.10% -14.24%
Debt-free Net Working Capital to Revenue
0.00% 3.92% 2.51% 0.25%
Net Working Capital to Revenue
0.00% 2.10% 0.63% -1.72%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $1.11 $2.20
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 72.20M 73.50M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $1.08 $2.14
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 74.20M 75.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 73.04M 73.56M
Normalized Net Operating Profit after Tax (NOPAT)
173 184 283 410
Normalized NOPAT Margin
4.20% 4.40% 6.58% 9.41%
Pre Tax Income Margin
3.54% 2.13% 2.90% 4.34%
Debt Service Ratios
- - - -
EBIT to Interest Expense
5.71 1.99 1.38 1.70
NOPAT to Interest Expense
5.59 -4.86 0.85 1.52
EBIT Less CapEx to Interest Expense
2.58 0.52 1.00 1.29
NOPAT Less CapEx to Interest Expense
2.46 -6.33 0.47 1.11
Payout Ratios
- - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 17.28%

Quarterly Metrics And Ratios for NCR Atleos

This table displays calculated financial ratios and metrics derived from NCR Atleos' official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - 73,904,136.00 73,561,203.00 73,779,817.00 73,896,934.00
DEI Adjusted Shares Outstanding
- - - - - - - 73,904,136.00 73,561,203.00 73,779,817.00 73,896,934.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - 1.00 0.30 0.88 1.31
Growth Metrics
- - - - - - - - - - -
Revenue Growth
6.49% 3.85% 0.56% 0.37% -6.67% 2.22% 4.47% 4.27% 6.54% 0.09% -1.96%
EBITDA Growth
17.46% 30.71% 15.09% 2,700.00% 9.46% 11.48% -6.56% -13.85% 5.06% 13.13% 53.22%
EBIT Growth
13.64% 40.00% 13.54% 346.03% 24.00% 17.86% -7.34% -17.90% 7.87% 20.63% 88.12%
NOPAT Growth
27.96% 73.28% 231.87% 357.90% 17.22% -11.69% 14.04% 98.94% 1.90% 42.02% 58.77%
Net Income Growth
-121.62% -44.23% 135.09% 120.56% 300.00% 51.72% 30.00% 90.00% 69.23% 71.05% 273.08%
EPS Growth
-121.57% -45.33% 134.15% 117.97% 309.09% 46.34% 21.43% 94.00% 52.63% 65.38% 273.53%
Operating Cash Flow Growth
23.33% -88.75% -27.21% 900.00% -16.89% -355.56% -76.64% 188.75% -107.32% 220.00% 633.33%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% 106.22% 104.09% 101.70% -16.18% -109.62% -39.93% 213.14%
Invested Capital Growth
0.00% 0.00% 0.00% -4.70% -3.85% -0.76% 1.70% -0.20% 2.81% 2.03% 0.15%
Revenue Q/Q Growth
-4.37% 2.86% -0.65% 1.76% -11.55% 12.65% 1.54% 2.50% -9.23% 5.75% -0.36%
EBITDA Q/Q Growth
469.23% 23.65% 0.00% 17.89% -31.06% 25.93% -16.18% 16.37% -16.58% 34.94% 16.96%
EBIT Q/Q Growth
266.67% 49.33% -2.68% 33.62% -43.98% 41.94% -23.48% 31.68% -27.82% 58.33% 25.00%
NOPAT Q/Q Growth
105.71% 88.31% -19.92% 16.99% -40.92% 41.87% 3.41% 98.94% -67.52% 101.19% 22.13%
Net Income Q/Q Growth
95.12% 462.50% -31.03% 60.87% -67.35% 175.00% -40.91% 192.31% -71.05% 195.45% 49.23%
EPS Q/Q Growth
95.30% 472.73% -31.71% 43.75% -63.49% 160.87% -43.33% 185.29% -70.10% 196.55% 47.67%
Operating Cash Flow Q/Q Growth
1,750.00% -93.92% 1,088.89% -25.23% 53.75% -118.70% 208.70% 824.00% -103.90% 433.33% 560.00%
Free Cash Flow Firm Q/Q Growth
0.00% 1.42% 1.26% 108.43% -25.54% -35.15% -58.90% 315.82% -108.45% 497.78% 123.92%
Invested Capital Q/Q Growth
-2.27% 0.30% -1.94% -1.86% -1.83% 3.53% 0.50% -3.69% 2.61% 2.74% -1.35%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
21.05% 23.24% 23.86% 26.07% 23.98% 22.92% 24.17% 26.28% 22.44% 28.01% 25.75%
EBITDA Margin
14.10% 16.94% 17.06% 20.42% 16.53% 18.48% 15.25% 17.32% 15.92% 20.31% 23.84%
Operating Margin
6.86% 10.00% 10.62% 12.58% 9.80% 10.87% 9.81% 13.23% 8.05% 14.14% 16.65%
EBIT Margin
7.14% 10.37% 10.16% 14.13% 9.49% 11.96% 9.01% 11.58% 9.20% 13.78% 17.29%
Profit (Net Income) Margin
-0.76% 2.69% 1.86% 3.37% 1.63% 3.99% 2.32% 6.61% 2.11% 5.89% 8.83%
Tax Burden Percent
200.00% 87.88% 66.67% 62.71% 61.54% 69.84% 78.79% 113.43% 66.67% 72.22% 75.19%
Interest Burden Percent
-5.33% 29.46% 27.52% 38.06% 27.96% 47.73% 32.67% 50.38% 34.38% 59.21% 67.89%
Effective Tax Rate
0.00% 12.12% 33.33% 37.29% 38.46% 30.16% 21.21% -13.43% 33.33% 27.78% 24.81%
Return on Invested Capital (ROIC)
15.56% 28.67% 23.57% 13.08% 9.94% 12.36% 12.79% 25.81% 9.27% 17.10% 20.95%
ROIC Less NNEP Spread (ROIC-NNEP)
10.57% 23.14% 18.74% 10.99% 8.07% 10.65% 10.16% 21.46% 7.74% 14.96% 19.09%
Return on Net Nonoperating Assets (RNNOA)
86.07% 219.56% 165.96% 117.29% 65.43% 81.97% 79.06% 152.41% 51.03% 81.85% 93.13%
Return on Equity (ROE)
101.63% 248.23% 189.53% 130.37% 75.38% 94.34% 91.84% 178.22% 60.30% 98.95% 114.08%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 15.72% 16.53% 12.93% 10.38% 16.38% 12.89% 14.28% 17.86%
Operating Return on Assets (OROA)
5.26% 7.73% 7.59% 10.83% 7.00% 8.82% 6.81% 9.00% 7.15% 10.61% 13.63%
Return on Assets (ROA)
-0.56% 2.00% 1.39% 2.58% 1.20% 2.94% 1.75% 5.14% 1.64% 4.54% 6.96%
Return on Common Equity (ROCE)
100.21% 247.24% 190.98% 128.32% 74.44% 93.87% 92.00% 177.37% 60.03% 98.71% 114.08%
Return on Equity Simple (ROE_SIMPLE)
-62.54% 0.00% 0.00% 0.00% 42.18% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
50 95 76 87 59 84 87 172 56 113 138
NOPAT Margin
4.80% 8.79% 7.08% 7.89% 6.03% 7.59% 7.73% 15.01% 5.37% 10.21% 12.52%
Net Nonoperating Expense Percent (NNEP)
5.00% 5.53% 4.83% 2.09% 1.88% 1.71% 2.63% 4.35% 1.53% 2.14% 1.86%
Return On Investment Capital (ROIC_SIMPLE)
1.56% 2.91% 2.33% 2.74% 1.85% 2.58% 2.71% 5.46% 1.76% 3.46% 4.43%
Cost of Revenue to Revenue
78.95% 76.76% 76.14% 73.93% 76.02% 77.08% 75.83% 73.72% 77.56% 71.99% 74.25%
SG&A Expenses to Revenue
12.57% 12.22% 11.84% 11.85% 12.45% 10.51% 12.76% 11.49% 12.46% 12.06% 7.46%
R&D to Revenue
1.62% 1.02% 1.40% 1.64% 1.73% 1.54% 1.61% 1.57% 1.92% 1.81% 1.64%
Operating Expenses to Revenue
14.19% 13.24% 13.23% 13.49% 14.18% 12.05% 14.36% 13.05% 14.38% 13.87% 9.10%
Earnings before Interest and Taxes (EBIT)
75 112 109 155 93 132 101 133 96 152 190
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
148 183 183 224 162 204 171 199 166 224 262
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 7.79 7.82 11.23 7.01 5.99 8.77 6.99 8.10 6.90 5.92
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.45 0.48 0.57 0.45 0.49 0.67 0.65 0.73 0.72 0.76
Price to Earnings (P/E)
0.00 0.00 0.00 30.73 16.61 16.00 23.14 17.39 18.86 16.34 12.50
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 3.25% 6.02% 6.25% 4.32% 5.75% 5.30% 6.12% 8.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.65 1.70 1.88 1.65 1.67 1.98 1.95 2.08 2.03 2.06
Enterprise Value to Revenue (EV/Rev)
0.00 1.01 1.02 1.11 0.98 1.02 1.20 1.14 1.22 1.22 1.23
Enterprise Value to EBITDA (EV/EBITDA)
0.00 9.58 9.00 6.41 6.72 6.79 8.37 6.72 7.26 7.02 6.28
Enterprise Value to EBIT (EV/EBIT)
0.00 18.20 18.80 10.42 8.59 8.61 10.63 10.77 11.60 10.99 9.30
Enterprise Value to NOPAT (EV/NOPAT)
0.00 20.22 19.50 16.86 12.86 13.65 16.51 12.06 13.48 12.57 11.42
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 13.88 16.11 13.88 13.09 15.19 25.31 13.88 24.13 19.37 12.01
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 11.70 9.81 12.85 19.19 11.92 16.38 14.34 11.51
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
10.23 11.97 11.43 13.18 10.48 8.23 8.67 6.86 7.03 6.02 4.52
Long-Term Debt to Equity
9.95 11.64 11.09 12.82 10.19 8.00 8.43 6.65 6.83 5.84 4.36
Financial Leverage
8.15 9.49 8.86 10.67 8.11 7.70 7.78 7.10 6.60 5.47 4.88
Leverage Ratio
20.13 22.97 21.94 25.25 20.38 19.20 19.22 17.92 16.88 14.07 12.48
Compound Leverage Factor
-1.07 6.77 6.04 9.61 5.70 9.16 6.28 9.03 5.80 8.33 8.47
Debt to Total Capital
91.10% 92.29% 91.95% 92.95% 91.29% 89.17% 89.66% 87.28% 87.54% 85.76% 81.88%
Short-Term Debt to Total Capital
2.48% 2.58% 2.70% 2.56% 2.54% 2.49% 2.50% 2.72% 2.52% 2.58% 2.86%
Long-Term Debt to Total Capital
88.62% 89.71% 89.25% 90.39% 88.75% 86.67% 87.16% 84.56% 85.03% 83.19% 79.02%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.12% 0.03% -0.06% 0.13% 0.09% 0.06% 0.03% -0.03% 0.00% 0.00% -0.03%
Common Equity to Total Capital
8.78% 7.68% 8.11% 6.92% 8.62% 10.77% 10.31% 12.75% 12.46% 14.24% 18.15%
Debt to EBITDA
7.79 6.65 6.15 3.95 4.69 4.51 4.63 3.75 3.74 3.63 2.95
Net Debt to EBITDA
6.20 5.27 4.76 3.10 3.62 3.52 3.70 2.89 2.96 2.86 2.40
Long-Term Debt to EBITDA
7.58 6.46 5.97 3.84 4.56 4.39 4.50 3.63 3.63 3.52 2.85
Debt to NOPAT
-2.46 14.03 13.32 10.38 8.98 9.07 9.13 6.73 6.94 6.50 5.37
Net Debt to NOPAT
-1.96 11.12 10.32 8.16 6.92 7.08 7.30 5.19 5.48 5.12 4.37
Long-Term Debt to NOPAT
-2.39 13.64 12.93 10.10 8.73 8.82 8.87 6.52 6.74 6.30 5.19
Altman Z-Score
0.00 1.09 1.11 1.20 1.08 1.12 1.22 1.22 1.27 1.34 1.40
Noncontrolling Interest Sharing Ratio
1.39% 0.40% -0.76% 1.57% 1.24% 0.50% -0.17% 0.48% 0.45% 0.25% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.05 1.07 1.07 1.02 1.03 1.05 1.02 0.96 0.98 1.03 0.90
Quick Ratio
0.58 0.58 0.57 0.58 0.54 0.54 0.55 0.53 0.54 0.57 0.45
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-2,575 -2,538 -2,506 212 160 104 43 177 -15 60 134
Operating Cash Flow to CapEx
493.33% 28.13% 324.24% 258.06% 300.00% -65.71% 80.65% 825.00% -24.32% 81.08% 396.00%
Free Cash Flow to Firm to Interest Expense
-32.59 -32.13 -31.72 2.20 2.39 1.50 0.63 2.69 -0.24 0.96 2.19
Operating Cash Flow to Interest Expense
1.87 0.11 1.35 0.83 1.84 -0.33 0.37 3.50 -0.14 0.48 3.25
Operating Cash Flow Less CapEx to Interest Expense
1.49 -0.29 0.94 0.51 1.22 -0.84 -0.09 3.08 -0.73 -0.11 2.43
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.74 0.75 0.75 0.77 0.74 0.74 0.76 0.78 0.78 0.77 0.79
Accounts Receivable Turnover
5.73 6.08 6.90 6.68 6.07 6.21 7.23 7.70 7.17 6.96 8.08
Inventory Turnover
10.26 10.31 9.62 10.27 9.33 8.84 8.87 10.15 9.29 8.79 8.77
Fixed Asset Turnover
9.23 9.40 9.40 9.14 9.04 9.12 9.15 8.84 8.94 8.80 8.60
Accounts Payable Turnover
6.39 5.94 6.19 6.15 5.97 5.54 6.06 5.58 5.89 5.54 5.57
Days Sales Outstanding (DSO)
63.65 60.08 52.93 54.60 60.16 58.80 50.51 47.41 50.93 52.45 45.16
Days Inventory Outstanding (DIO)
35.57 35.41 37.96 35.56 39.12 41.29 41.14 35.97 39.27 41.55 41.64
Days Payable Outstanding (DPO)
57.13 61.46 58.94 59.39 61.14 65.93 60.25 65.45 61.96 65.83 65.57
Cash Conversion Cycle (CCC)
42.09 34.03 31.95 30.77 38.15 34.16 31.40 17.92 28.25 28.16 21.23
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,625 2,633 2,582 2,534 2,524 2,613 2,626 2,529 2,595 2,666 2,630
Invested Capital Turnover
3.24 3.26 3.33 1.66 1.65 1.63 1.65 1.72 1.73 1.67 1.67
Increase / (Decrease) in Invested Capital
2,625 2,633 2,582 -125 -101 -20 44 -5.00 71 53 4.00
Enterprise Value (EV)
0.00 4,332 4,381 4,774 4,176 4,359 5,189 4,942 5,405 5,405 5,405
Market Capitalization
0.00 1,949 2,063 2,459 1,927 2,096 2,893 2,816 3,206 3,203 3,339
Book Value per Share
$3.95 $3.47 $3.65 $3.02 $3.77 $4.76 $4.48 $5.45 $5.38 $6.29 $7.63
Tangible Book Value per Share
($31.76) ($31.85) ($31.43) ($31.47) ($30.52) ($29.09) ($29.19) ($27.78) ($27.68) ($26.35) ($24.67)
Total Capital
3,224 3,256 3,256 3,163 3,192 3,249 3,200 3,160 3,179 3,259 3,107
Total Debt
2,937 3,005 2,994 2,940 2,914 2,897 2,869 2,758 2,783 2,795 2,544
Total Long-Term Debt
2,857 2,921 2,906 2,859 2,833 2,816 2,789 2,672 2,703 2,711 2,455
Net Debt
2,338 2,382 2,320 2,311 2,246 2,261 2,295 2,127 2,199 2,202 2,067
Capital Expenditures (CapEx)
30 32 33 31 41 35 31 28 37 37 50
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-419 -413 -454 -521 -538 -466 -461 -620 -540 -463 -562
Debt-free Net Working Capital (DFNWC)
180 210 220 108 130 170 113 11 44 130 -85
Net Working Capital (NWC)
100 126 132 27 49 89 33 -75 -36 46 -174
Net Nonoperating Expense (NNE)
58 66 56 50 43 40 61 96 34 48 41
Net Nonoperating Obligations (NNO)
2,338 2,382 2,320 2,311 2,246 2,261 2,295 2,127 2,199 2,202 2,067
Total Depreciation and Amortization (D&A)
73 71 74 69 69 72 70 66 70 72 72
Debt-free, Cash-free Net Working Capital to Revenue
-9.85% -9.62% -10.57% -12.10% -12.67% -10.91% -10.70% -14.24% -12.22% -10.48% -12.78%
Debt-free Net Working Capital to Revenue
4.23% 4.89% 5.12% 2.51% 3.06% 3.98% 2.62% 0.25% 1.00% 2.94% -1.93%
Net Working Capital to Revenue
2.35% 2.93% 3.07% 0.63% 1.15% 2.08% 0.77% -1.72% -0.81% 1.04% -3.96%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.11) $0.40 $0.33 $0.47 $0.23 $0.61 $0.35 $1.01 $0.30 $0.88 $1.31
Adjusted Weighted Average Basic Shares Outstanding
71.60M 72.20M 72.30M 72.20M 73.10M 73.50M 73.70M 73.50M 73.60M 73.80M 73.90M
Adjusted Diluted Earnings per Share
($0.11) $0.39 $0.32 $0.46 $0.23 $0.60 $0.34 $0.97 $0.29 $0.86 $1.27
Adjusted Weighted Average Diluted Shares Outstanding
71.60M 73.70M 74.50M 74.20M 75.20M 74.90M 76M 75.60M 75.60M 75.80M 76.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
72.12M 72.32M 72.49M 73.04M 73.45M 73.59M 73.90M 73.56M 73.78M 73.90M 73.94M
Normalized Net Operating Profit after Tax (NOPAT)
50 95 76 87 59 84 87 106 56 113 138
Normalized NOPAT Margin
4.80% 8.79% 7.08% 7.89% 6.03% 7.59% 7.73% 9.26% 5.37% 10.21% 12.52%
Pre Tax Income Margin
-0.38% 3.06% 2.80% 5.38% 2.65% 5.71% 2.94% 5.83% 3.16% 8.16% 11.74%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.95 1.42 1.38 1.61 1.39 1.91 1.49 2.02 1.52 2.45 3.11
NOPAT to Interest Expense
0.64 1.20 0.96 0.90 0.88 1.21 1.27 2.61 0.89 1.82 2.26
EBIT Less CapEx to Interest Expense
0.57 1.01 0.96 1.29 0.78 1.41 1.03 1.59 0.94 1.85 2.30
NOPAT Less CapEx to Interest Expense
0.26 0.80 0.54 0.58 0.27 0.71 0.82 2.19 0.30 1.22 1.44
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 17.28% 25.73% 22.22% 16.36%

Financials Breakdown Chart

Key Financial Trends

NCR Atleos’ second-quarter 2026 results show meaningful improvement in profitability, although cash generation and leverage remain important risks. Revenue increased to $1.103 billion from $1.043 billion in the first quarter and $1.102 billion in the year-ago quarter. The company’s gross margin expanded to approximately 28.0%, compared with 22.4% in Q1 2026 and 22.9% in Q2 2025.

Operating income rose to $156 million in Q2 from $84 million in Q1 and $119 million in Q2 2025. Operating margin reached roughly 14.1%, the strongest level among the comparable quarterly figures provided. Net income attributable to common shareholders increased to $65 million, or $0.86 per diluted share, versus $22 million, or $0.29 per share, in Q1 2026.

  • Profitability improved sharply. Q2 2026 operating income more than doubled sequentially, while the operating margin improved to approximately 14.1% from 8.1% in Q1.
  • Gross-margin expansion is encouraging. Gross profit increased to $309 million in Q2 from $234 million in Q1, despite revenue rising only 5.8% sequentially. This suggests better cost absorption or a more favorable revenue mix.
  • Interest expense is trending lower. Quarterly interest expense declined to $62 million from $63 million in Q1, $66 million in Q4 2025 and $69 million in Q2 2025. Total debt also fell to approximately $2.795 billion from $2.897 billion a year earlier.
  • Cash-flow performance improved year over year. Operating cash flow was $30 million in Q2 2026, compared with negative $23 million in the restated Q2 2025 period. The company also reported a $9 million increase in cash and equivalents during Q2, versus a $48 million decline in Q1.
  • Working-capital trends were less damaging than a year ago. The use of cash from operating assets and liabilities improved to $85 million in Q2 2026 from $113 million in Q2 2025, although it remained a cash headwind.
  • Revenue growth remains modest. Q2 revenue was essentially flat year over year and remains below Q4 2025’s $1.149 billion. Investors will need to determine whether the recent margin improvement can continue without stronger top-line growth.
  • Cash reserves remain substantial but include restricted cash. NCR Atleos reported $429 million of unrestricted cash and $164 million of restricted cash at quarter-end. The distinction is important because restricted cash may not be readily available for debt repayment or general corporate needs.
  • Free cash flow was approximately negative $7 million in Q2. Operating cash flow of $30 million did not fully cover $37 million of capital expenditures. This follows estimated free cash flow of negative $46 million in Q1 and indicates that earnings are not yet consistently converting into discretionary cash.
  • Balance-sheet leverage remains high. Total liabilities of $5.2 billion represented roughly 92% of total assets, while shareholders’ equity was only $464 million. The current ratio was approximately 1.03, leaving limited excess current-asset coverage over current liabilities.
  • Goodwill and intangible assets create impairment risk. Goodwill of $1.957 billion and intangible assets of $451 million totaled approximately $2.4 billion, or more than 40% of total assets. A deterioration in operating performance could increase the risk of non-cash impairment charges.

Across the reported periods, NCR Atleos has moved from the severe loss recorded in Q4 2023 to consistently positive earnings in the subsequent quarters. However, cash flow has been uneven: operating cash flow was strong in Q4 2025 at $231 million, but was negative in Q1 2025 and Q1 2026 before turning positive in Q2 2026. Investors should therefore watch several more quarters of operating cash flow and free cash flow before treating the Q2 improvement as a durable trend.

The company’s improving margins, rising earnings per share and declining interest expense are constructive. Still, the combination of high debt, a thin equity cushion and weak recent free cash flow means that NCR Atleos remains financially sensitive to any slowdown in revenue or renewed pressure on margins. Several historical periods in the dataset are identified as restated, so comparisons should be interpreted using the latest revised figures where available.

11/20/26 04:27 PM ETAI Generated. May Contain Errors.

NCR Atleos Financials - Frequently Asked Questions

According to the most recent income statement we have on file, NCR Atleos' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

NCR Atleos' net income appears to be on an upward trend, with a most recent value of $162 million in 2025, rising from $98 million in 2022. The previous period was $81 million in 2024. Check out NCR Atleos' forecast to explore projected trends and price targets.

NCR Atleos' total operating income in 2025 was $478 million, based on the following breakdown:
  • Total Gross Profit: $1.06 billion
  • Total Operating Expenses: $583 million

Over the last 3 years, NCR Atleos' total revenue changed from $4.12 billion in 2022 to $4.35 billion in 2025, a change of 5.6%.

In the past 10 quarters, NCR Atleos' cash and equivalents has ranged from $311 million in Q3 2026 to $433 million in Q1 2026, and is currently $311 million as of their latest financial filing in Q3 2026.

NCR Atleos had total debt of $2.76 billion at the end of 2025, a 6.2% decrease from 2024, and none in 2022.

Over the last 3 years, NCR Atleos' book value per share changed from 0.00 in 2022 to 5.45 in 2025, a change of 545.3%.



Financial statements for NYSE:NATL last updated on 11/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners